Pharmacy Consulting

Pharmacy Healthcare Solutions Inc. (PHSI) consults with pharmaceutical manufacturers, PBMs, pharmacies (retail, specialty, mail service, LTC, and hospital outpatient), and technology companies on strategic business and marketing issues. Consulting projects across these market segments provide PHSI with the latest information on emerging trends as well as new products and services. Our consultants have extensive retail, mail service and managed care experience to create actionable recommendations for our clients’ challenging business issues.

News & Events

PHSI to Attend AMCP Nexus 2019

PHSI Vice President Don Dietz, Director of Business Development Fred Hamlin, and Consultants & PHSI partners Ann Johnson and Melissa Krause will be attending AMCP Nexus 2019 in National Harbor, Maryland on October 29th – November 1st. To schedule a meeting with Don, Fred, Ann, or Melissa during the conference, click here to contact PHSI.

ComputerTalk for the Pharmacist July/August 2019

PHSI Consultant and Partner Ann Johnson contributed to the July/August 2019 edition of ComputerTalk for the Pharmacist. In the Viewpoints article, Ann discusses the biosimilar four-character suffix assignments and the impact of these suffixes on product appearance in EHRs, pharmacy management systems, and wholesaler ordering systems. Click here to read Ann’s article entitled “Impact of Read More →

Digital Therapeutics & The Role of the Pharmacist presented at ASAP by Ann Johnson

PHSI Consultant, Partner Ann Johnson presented at the American Society for Automation in Pharmacy (ASAP) 2019 Midyear Conference. Along with a background on digital therapeutics, Ann discussed the FDA’s Proposed Framework for “Prescription Drug-Use-Related Software” and opportunities for adherence initiatives, data available from digital therapeutics, and the role that pharmacists can play. Click here to view Read More →

Latest from the Blog

A Comparison of Direct Patient Care Services in Large Chain Pharmacies

In an era of dwindling prescription reimbursements and high brand drug costs, community pharmacies nationwide are actively expanding their clinical and direct patient care services to both supplement traditional prescription revenue and to meet the ever-increasing demand for affordable, reliable, and easily accessible patient care. Three key competitors in chain pharmacy, Rite Aid, CVS, and Read More →

Update: Mandating Price Reporting in Prescription Drug Advertisements

In May 2019, PHSI published a blog discussing the Department of Health and Human Services (HHS) agreement to move forward with one of the initiatives of the Trump Administration’s “American Patients First” blueprint. Part of the “American Patients First” initiative  would require drug manufacturers to report list prices on prescription drug advertisements, in hopes that Read More →

Medicaid Rebates and the Impact of Authorized Generics

Excluding Authorized Generics from Brand Drug AMP Calculations The Office of Inspector General (OIG) published a review in April 2019 assessing how excluding authorized generics from average manufacturer price (AMP) calculations would impact Medicaid drug rebates. This review was prompted by a 2017 HHS Budget Brief, which stated that excluding authorized generics could save Medicaid Read More →